BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs7903146
,
FABP1
,
T cell receptor signaling pathway
,
Arthritis
,
Heart
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sars cov protein
Summary
General Info
Curated Studies
Most Correlated Studies
Monocytes from PBMCs of healthy donors treated with SARS-CoV-2 mimic of IL-17A ORF8 and IL-17A
Ferret gene response to SARS coronavirus infection and IFN-a2b injection
Hearts and hemocytes of D. melanogaster with overexpression of SARS-CoV-2 proteins
Embryonic kidney HEK293 cells overexpressing SARS-CoV-2 N protein treated with sodium arsenite
Leukemia monocytic THP-1 cells treated with SARS-CoV-2 spike protein
Explore Curated Studies Results
Literature
Most Relevant Literature
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine…
Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of …
Anti-N SARS-CoV-2 assays for evaluation of natural viral infection.
Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COV…
Disruption of the Golgi Apparatus and Contribution of the Endoplasmic Reticulum to the SARS-CoV-2 Re…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ